Access Doesn’t End at the Prescription

For pharmaceutical manufacturers and life science partners, bringing a therapy to market is only part of the access challenge. Coverage and approval open the door, but they don’t clear everything standing between a patient and treatment. Patients can still be left with lab work they need to complete first, vaccines they need before starting and monitoring that has to happen along the way. Each of these steps can slow a patient’s start or interrupt therapy once it’s underway.

These are the non-drug barriers to access, and they’re getting more attention as partners look for ways to keep patients moving from prescription to first dose.

Naven works in combination with prescribers and care teams to handle those clinical steps in the patient’s home. This is where wraparound clinical services come in.

Care that goes beyond administration

Naven’s core work has traditionally centered on therapy administration, which usually means a nurse goes to the home to administer a specialty therapy or to teach a patient how to do it themselves. Wraparound clinical services are the layer that sits around that work. They include in-home lab collection, vaccine administration and monitoring before and after therapy.

In-home lab collection lets a patient complete required bloodwork without traveling to a separate facility, which can be the difference between starting on time and waiting weeks. Vaccine administration removes another prerequisite that can hold up the start of certain therapies. Monitoring before and after therapy helps the care team track how a patient is responding and catch issues early.

Some of this work doesn’t involve the therapy itself at all. Naven has recently begun supporting oral therapies where nurses handle the surrounding lab work rather than administering a drug. That kind of work is a meaningful shift, because it shows how care at home can support a patient’s treatment even when there’s no infusion or injection involved.

A national network behind the work

Wraparound services only matter if a partner can count on them being delivered consistently across the country. Naven has supported more than 350 therapies and provides care at home across all 50 states, backed by one of the nation’s largest nursing networks. Patient satisfaction has held at 96 percent.

Because these nurses are highly skilled and work in combination with the patient’s broader care team, partners can extend their patient support beyond the prescription and into the home.

Where this leaves partners

For manufacturers and life science partners, wraparound clinical services offer a way to remove more of the friction that can delay or derail therapy. The fewer non-drug steps a patient has to manage on their own, the more likely they are to start and stay on treatment.

For partners looking to close those gaps, Naven brings the labs, vaccines and monitoring into the home, so fewer of those steps fall to the patient.